Literature DB >> 830220

Quantification of infarction in cross sections of canine myocardium in vivo with positron emission transaxial tomography and 11C-palmitate.

E S Weiss, S A Ahmed, M J Welch, J R Williamson, M M Ter-Pogossian, B E Sobel.   

Abstract

To assess myocardial infarction quantitatively in 15 mm thick transverse sections of the canine heart in vivo we utilized a new technique, positron emission transaxial tomography (PETT) and cyclotron-produced 11C-palmitate (11C-P) injected intravenously. Results were compared to regional myocardial creatine phosphokinase (CPK) depletion, diminished 14C-palmitate accumulation in tissue extracts, and infarction estimated morphometrically 48 hours after coronary occlusion. CPK activity and 14C-P content declined in parallel in transmural biopsies (N=44) from normal and ischemic zones (r=.92) in six dogs; and infarct in 10 mm thick cross sections of the entire left ventricle estimated morphometrically (N=26) in six other animals correlated with CPK depletion in contiguous 2.5 mm thick slices (r=.92). When the percentage of infarction in 15 mm thick cross sections was assessed tomographically in six other dogs 48 hours after coronary occlusion with 11C-P injected intravenously, results correlated with infarction in corresponding cross sections from the same hearts estimated morphometrically (r=.97, N=9) and by analysis of CPK depletion (r=.93, N=9). Thus, PETT permits estimation of infarction in cross sections of the left ventricle in vivo after intravenous injection of 11C-palmitate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830220     DOI: 10.1161/01.cir.55.1.66

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Con.

Authors:  Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 2.  Advantages and limitations of experimental techniques used to measure cardiac energy metabolism.

Authors:  G D Lopaschuk
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

Review 3.  History and future technical innovation in positron emission tomography.

Authors:  Terry Jones; David Townsend
Journal:  J Med Imaging (Bellingham)       Date:  2017-03-31

4.  Emission tomography of the heart: principles and applications.

Authors:  J S Zielonka; B L Holman
Journal:  Cardiovasc Radiol       Date:  1979-09

Review 5.  The character of transient myocardial ischemia: clinical studies and progress using positron emission tomography.

Authors:  A P Selwyn; M Shea; J Deanfield; R Wilson; C DeLandsheere; T Jones
Journal:  Int J Card Imaging       Date:  1985

Review 6.  Clinical applications of assessments of myocardial substrate utilization with positron emission tomography.

Authors:  S R Bergmann
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

7.  Evaluation of myocardial infarct size in rat heart by pinhole SPECT.

Authors:  T Hirai; R Nohara; R Hosokawa; M Tanaka; H Inada; Y Fujibayashi; M Fujita; J Konishi; S Sasayama
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 8.  Positron emission tomography. Diagnostic and therapeutic implications in human myocardial ischemia.

Authors:  H R Schelbert
Journal:  Int J Card Imaging       Date:  1987

Review 9.  The Potential of Metabolic Imaging.

Authors:  Valentina Di Gialleonardo; David M Wilson; Kayvan R Keshari
Journal:  Semin Nucl Med       Date:  2016-01       Impact factor: 4.446

Review 10.  Cardiac nuclear medicine: positron emission tomography in clinical medicine.

Authors:  A Storch-Becker; K P Kaiser; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.